New hope for liver cancer patients when first treatment stops working
NCT ID NCT05168163
Summary
This study is for people with advanced liver cancer that cannot be removed by surgery and has continued to grow despite their first treatment. Researchers want to see if continuing one of the original drugs (atezolizumab) alongside a new type of drug (cabozantinib or lenvatinib) works better than just the new drug alone. The goal is to better control the cancer, slow its growth, and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny General Hospital
RECRUITINGPittsburgh, Pennsylvania, 15212, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Carle Cancer Center NCI Community Oncology Research Program
RECRUITINGUrbana, Illinois, 61801, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Cleveland Clinic Weston Florida
WITHDRAWNWeston, Florida, 33331, United States
-
Duke University Medical Center
COMPLETEDDurham, North Carolina, 27710, United States
-
Froedtert and the Medical College of Wisconsin LAPS
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic in Arizona
RECRUITINGScottsdale, Arizona, 85259, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic in Florida
WITHDRAWNJacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Michigan Cancer Research Consortium NCORP
RECRUITINGAnn Arbor, Michigan, 48106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Rapid City Regional Hospital
RECRUITINGRapid City, South Dakota, 57701, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospitals Cleveland Medical Center
WITHDRAWNCleveland, Ohio, 44106, United States
-
University Medical Center New Orleans
RECRUITINGNew Orleans, Louisiana, 70112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Chicago Comprehensive Cancer Center
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Michigan Comprehensive Cancer Center
NOT_YET_RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.